It is caused by a reactivation of the Herpes zoster virus - the virus that causes chicken pox. A vaccine against shingles was introduced in many countries about 18 years ago. Since then there has ...

The Advisory Committee on Immunization Practices (ACIP) recommends a single dose of zoster vaccine for immunocompetent adults 60 years of age and older, based on the results of this study ...

Older people who avail themselves of the newest shingles vaccine could reap a hidden benefit: A significant drop in their ...

However HIV-related immunosuppression might compromise HCV vaccine responses and effectiveness. The ideal prophylactic and therapeutic HCV vaccines for HIV-coinfected individuals therefore need to ...

Company chief commercial officer Luke Miels says GSK internal data is showing “a correlation” between those who had taken the company’s shingles vaccine, Shingrix, and a lower risk of ...

Jamie Mackelfresh, MD: Currently, the CDC recommends that adults over age 50, in particular, are the core people who should think about getting the shingles vaccine. There are two different ...

SEATTLE, Oct. 31, 2024 (GLOBE NEWSWIRE) -- Curevo Vaccine (Curevo), a privately-held clinical-stage biotechnology company dedicated to developing varicella zoster virus (VZV) vaccines with ...

“I’m optimistic and believe Shingrix will also be effective at reducing shingles and its sequelae, especially with how effective the vaccine has shown to be in other settings,” said Harris. Harris ...

What does the shingles rash looks like? Who’s at risk? And who needs the shingles vaccine? Get your questions answered in this WebMD slideshow. There are some common misconceptions about this ...

Oct. 17, 2024 — With viral outbreaks spreading more quickly, faster responses and quicker development of new vaccines has become crucial. However, production of the mRNA used in vaccines is ...

GSK on Wednesday said its vaccine sales would fall this year, after a weaker-than-expected performance for its respiratory ...

Zero shingles cases after 18.8 months follow-up in 619 patients receiving any dose of amezosvatein, a development-stage adjuvanted subunit ...